Lamisil News
Most Popular Lamisil Story
FDA backs pediatric warnings on Zyprexa, Lamisil
In advance of tomorrow's pediatric advisory committee meeting at the FDA, agency staffers are recommending new cautionary language for Eli Lilly's antipsychotic Zyprexa (about the risks of weight Read more...
Latest Headlines
- November 17, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
